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A B S T R A C T
There is emerging evidence for the involvement of reactive oxygen species (ROS) in the regulation of stem cells
and cellular diﬀerentiation. Absence of the ROS-generating NADPH oxidase NOX2 in chronic granulomatous
disease (CGD) patients, predominantly manifests as immune deﬁciency, but has also been associated with
decreased cognition. Here, we investigate the role of NOX enzymes in neuronal homeostasis in adult mouse brain
and in neural cells derived from human induced pluripotent stem cells (iPSC). High levels of NOX2 were found in
mouse adult neurogenic regions. In NOX2-deﬁcient mice, neurogenic regions showed diminished redox
modiﬁcations, as well as decrease in neuroprecursor numbers and in expression of genes involved in neural
diﬀerentiation including NES, BDNF and OTX2. iPSC from healthy subjects and patients with CGD were used to
study the role of NOX2 in human in vitro neuronal development. Expression of NOX2 was low in
undiﬀerentiated iPSC, upregulated upon neural induction, and disappeared during neuronal diﬀerentiation. In
human neurospheres, NOX2 protein and ROS generation were polarized within the inner cell layer of rosette
structures. NOX2 deﬁciency in CGD-iPSCs resulted in an abnormal neural induction in vitro, as revealed by a
reduced expression of neuroprogenitor markers (NES, BDNF, OTX2, NRSF/REST), and a decreased generation of
mature neurons. Vector-mediated NOX2 expression in NOX2-deﬁcient iPSCs rescued neurogenesis. Taken
together, our study provides novel evidence for a regulatory role of NOX2 during early stages of neurogenesis in
mouse and human.
1. Introduction
There is increasing evidence for the role of reactive oxygen species
(ROS) in developmental processes, such as cardiomyogenesis [33,7,8],
hematopoiesis [48,49], and neurogenesis [14,30,42,54,59,66,67]. This
role of ROS might at least in part be due to a regulatory role in stem cell
homeostasis and diﬀerentiation. Several redox-sensitive signaling path-
ways have been described, including H2O2-dependent protein phos-
phatase inhibition, as well as redox-regulation of transcription factors
and ion channels [19].
There is a wide range of possible cellular sources of ROS, including
mitochondria, xanthine oxidase, lipoxygenase, cyclooxygenases, cyto-
chrome P450, nitric oxide synthase and peroxisomes [23]. In addition
to these systems that produce ROS as a side reaction, there is the NOX
family of NADPH oxidases (NOXs), for which production of ROS is the
main biological function [3,32]. Enzymes of the NOX family include the
phagocyte NAPDH oxidase NOX2, as well as more recently discovered
isoforms (NOX1, NOX3-5, and DUOX1-2). NOXs are highly regulated
enzymes, with some of the isoforms (NOX1-NOX4) functioning in a
subunit-dependent manner. For example, NOX2 functions as a complex
containing at least ﬁve subunits (p22phox, p47phox, p67phox and p40phox,
and small Rac GTPases) [29]. Loss of function mutations in any of the
constituents of the NOX2 complex leads to the genetic disorder chronic
granulomatous disease (CGD). CGD patients predominantly show an
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immunological phenotype, including susceptibility to infection, hyper
inﬂammation and autoimmunity [55]. However, there is also evidence
for a role of NOX2 in the physiological function of the central nervous
system (CNS): NOX2-deﬁcient mice [26] and CGD patients [45] have a
discreet, but consistently observed cognitive impairment. Thus, the
question to which extent NOX2 plays a role in the physiological
function of the CNS is pertinent.
Basically there are two main concepts to explain how ROS might be
involved in the physiological function of the CNS: modulation of the
function of mature neurons [12,24,25,27,31,43,4,52,58,61] versus
impact on neural development and neurogenesis [14,30,31,59]. These
two concepts are not mutually exclusive and the nature of ROS
regulation might depend on the brain area and neural cell types. For
instance, RNAseq studies in the murine cerebral cortex demonstrate
that under physiological conditions, NOX2 is mostly expressed in
microglia, while NOX4 is mostly found in endothelial cells [68].
However, several recent publications suggest that NOX2 is highly
expressed in neural progenitor cells (NPCs) in murine adult neurogenic
regions: the subventricular zone (SVZ) of the lateral ventricle and the
dentate gyrus (DG) of the mouse hippocampus [30,60,67]. These
regions contain adult neural stem cells (NSCs) and diﬀerentiate into
neural progenitors which migrate, mature and are ﬁnally integrated
into various brain regions. Adult neurogenesis is not only involved in
brain repair, but regulates several physiological functions, in particular
memory [13].
A recent review on the role of redox environment in neurogenic
development [44] summarized the present knowledge as follows. The
cellular redox state during neurogenesis and neural diﬀerentiation
controls speciﬁc mechanism of lineage progression through control of
signal transduction and transcriptional regulation. More speciﬁcally,
redox-dependent mechanisms regulate NSC proliferation, cell cycle
exit, and diﬀerentiation into mature neurons and glia. Oxidizing species
accumulate during early stages of diﬀerentiation, while a reductive
environment persists during terminally diﬀerentiated neural cells. The
Fig. 1. NOX2 and subunits, but not microglia markers, are expressed in neurogenic regions of the mouse brain. (A) Schematic representation of micro-dissected adult mouse brain areas
(dashed blue lines) including the neurogenic regions dentate gyrus (DG) and subventricular zone (SVZ) and the non-neurogenic regions olfactory bulb (OB) and prefrontal cortex (PFC).
CBM: cerebellum, Hi: hippocampus, St: striatum, RMS: rostral migratory stream. (B-D, F-I) mRNA expression of NOX isoforms and NOX subunits in micro-dissected brain regions. The
following murine tissues were used as positive control; colon (Nox1), spleen (Nox2), and kidney (Nox4). (E) Schematic representation of the Nox2 complex including its subunits Cyba
(p22phox), Ncf1 (p47phox), Ncf2 (p67phox), Ncf4 (p40phox) and Rac. (J, L): expression of microglia markers Aif-1 (IBA-1) and Spi-1 (PU.1), in diﬀerent brain regions as assessed by RT-qPCR
(J, L) or by immunoﬂuorescence (K, M). ALS = spinal cord of mice overexpressing SOD1G93A mutant (a model for amyotrophic lateral sclerosis, ALS) served as a positive control for high
levels of microglial gene expression [51]. For RT-qPCR, expression values were normalized to housekeeping genes and data are shown as mean±SEM. Statistics were done by Student's t-
test from n =6. *P<0.05, **P<0.01, ***<0.001.
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generation of certain neurotrophic growth factors also appears to be
under redox control [47]. For example, there is a redox-regulation of
brain-derived neurotrophic factor BDNF [39,53], which contributes to
the self-renewal and survival of neural stem/progenitor cells during
neurogenesis, inﬂuencing memory and cognition [46,5,64]. These
ﬁndings on the role of redox-dependent processes in neurogenesis raise
the question whether NOX enzymes play a role during early stages of
neural diﬀerentiation.
While hitherto the study of neurodevelopmental processes was
mostly restricted to animal models, the availability of human pluripo-
tent stem cells provides now powerful tools to study the mechanisms
underlying cellular decisions during neural diﬀerentiation in a human
Fig. 2. Decreased oxidative modiﬁcations and proliferating neuroprecursor cells in neurogenic brain regions of NOX2-deﬁcient mice. Oxidative modiﬁcations of DNA (8-
hydroxydeoxyguanosine, 8-OHdG in Figure A, C) and lipids (4-hydroxynonenal; 4-HNE in Figure E, G) were detected using DAB immunohistochemistry in sections of the neurogenic
mouse brain regions. The SVZ and DG from wild type (WT) and NOX2-knock-out mice were analyzed. Arrows in panel A and E indicate intensely stained cells in the subgranular zone
(SGZ) of the dentate gyrus. (B, D, F and H) Quantiﬁcation of 8-OHdG and 4-HNE DAB staining are shown as bar graphs as % of positive cells per analyzed area as analyzed by Metamorph
software (see Material and Methods). Immunoﬂuorescence staining of proliferating progenitor cells in DG (I) and SVZ (K) of wild type and NOX2 KO mice. IF markers: Nestin (red); Ki67
(green); DAPI (blue). Quantiﬁcation of immunoﬂuorescence staining (% of double-positive cells/total cells) in the DG (J) and SVZ (L). Data are shown as mean± SEM. Statistics were
performed using Student's t-test from 8 animals per condition. (M) RT-qPCR analysis of Nes (nestin), neuroblast marker Dcx (doublecortin), Bdnf (brain derived neurotrophic factor) and
Otx2 transcription factor in neural stem/progenitor cells of DG and SVZ. Data are shown as mean± SEM. Statistics done by Student's t-test from n =7. *P< 0.05, **P< 0.01,
***< 0.001.
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system [15,56]. And, while there are many fundamental developmental
mechanisms shared between mice and humans, there are also consider-
able diﬀerences. For example, preclinical mouse studies did not predict
the teratogenicity of thalidomide while transcriptomic and proteomic
investigation of the compound using human embryonic stem cells
(hESCs) clearly indicated that thalidomide impacts several key devel-
opmental human genes at clinically relevant concentrations [40]. This
could be due to diﬀerences in the metabolism of the compounds.
In this study we have investigated the role of NOX2 during
neurogenesis in mice and in human induced pluripotent stem cells
(hiPSCs). For this purpose, we investigated brains from NOX2-deﬁcient
mice, as well as in NPCs and neurons diﬀerentiated from iPSCs derived
from NOX2-deﬁcient and p22phox-deﬁcient CGD patients. We show that
NOX2 is highly expressed in neurogenic regions of the mouse brain, as
well as in NPCs derived from hiPSCs. NOX2 deﬁciency or inhibition
decreases oxidative modiﬁcations in neural stem/precursor cells,
reduces the size of the neuroprogenitor pool, and impacts down-stream
neural diﬀerentiation. Correction of NOX2 expression in CGD-hiPSCs
was associated with the restoration of the expression to near normal
levels of crucial genes involved in neurogenesis. Our results provide
further evidence for a role of NOX2 in neurogenesis, unrelated to the
well-known function of the enzyme in inﬂammation and host defense.
2. Results
2.1. NOX expression and activity in neurogenic regions of the adult mouse
brain
To examine the expression and function of NOX enzymes and their
subunits in neurogenic regions [1], we ﬁrst investigated the subven-
tricular zone (SVZ) and the dentate gyrus (DG) isolated from adult
mouse brain (see Material and methods). In the SVZ, proliferating NPCs
are lining the lateral ventricles from where they migrate towards the
olfactory bulb and diﬀerentiate into granular interneuron cells
[35,36,38]. In the DG of the hippocampus, the sub-granular zone
(SGZ) contains precursor cells, which proliferate and migrate along the
granular cell layer to diﬀerentiate into hippocampal granule cells
[9,2,28] (Fig. 1A).
We studied the expression of the diﬀerent NOX isoforms in micro-
dissected neurogenic regions (see Methods) (Fig. 1B-D and Fig. S1D and
S1E). NOX1 and NOX4 expression was relatively low in neurogenic
brain regions, but showed higher levels in the prefrontal cortex (PFC)
and the olfactory bulb (OB). No relevant expression in neurogenic
regions was observed for Nox3 and the two Duox genes (Fig. S1D). In
contrast, Cybb (NOX2) was markedly higher in both neurogenic regions
as compared to PFC and OB (Fig. 1C). Similarly, Cyba (p22phox) and
Ncf1 (p47phox) as well as GTPase Rac1were signiﬁcantly higher
expressed in DG, SVZ and the olfactory bulb (Figs. 1F, 1G and 1H),
while there was no distinct pattern for Ncf4 (p40phox) and Ncf2
(p67phox) or for other GTPase Rac isoforms including Rac2 and Rac3
(Figs. 1H and 1I, and Fig. S1E). Note that the NOX2 enrichment in the
neurogenic regions is considerable as it approaches levels comparable
to those observed in spleen.
The CNS phagocyte microglia is the most relevant NOX2 expressing
cells in the brain and its presence might provide an explanation for the
high NOX2 levels observed in neurogenic regions [50]. We therefore
investigated microglia markers in the SVZ and the DG. The microglia
marker Aif1 (IBA-1) was expressed only at very low levels in neurogenic
regions (Figs. 1J and 1K). Similarly, the transcription factor Spi1 (PU.1)
which is highly expressed in microglia and other types of phagocytes
[3] was found at only very low levels in neurogenic regions (Figs. 1L
and 1M).
To assess the relative contribution of NOX2-derived ROS in murine
neurogenic areas, we investigated the levels and localization of
oxidative modiﬁcations of DNA (8-OHdG; 8-hydroxyguanosine) and
of lipids (4-HNE; 4-hydroxynonenal). Analysis of both markers revealed
elevated staining localizing to cells within SVZ and DG (Fig. 2A-H). In
the granular cell layer of the DG, the staining intensity of 8-OHdG was
strongest in the lower layer, i.e. the SGZ, which is enriched in
proliferating NPCs (Figs. 2A and 2B, arrow heads).
Staining for 8-OHdG and 4-HNE was markedly decreased in NOX2-
deﬁcient mice as compared to wild-type DG (Figs. 2A and 2E, left vs.
right panels) and SVZ (Figs. 2C and 2G, left vs. right panels).
Quantiﬁcation of staining showed lower levels of 8-OHdG (Figs. 2B
and 2D) and 4-HNE (Figs. 2F and 2H) in NOX2-deﬁcient mice
suggesting that NOX2 contributes to oxidative modiﬁcations in speciﬁc
subsets of cells of SVZ and DG. Thus, a signiﬁcant fraction of oxidative
modiﬁcations in the neurogenic areas can most likely be attributed to
NOX2-derived ROS. The residual oxidative modiﬁcations might be due
to low levels of other NOX isoforms (see Fig. S1D) or to distinct cellular
sources, such as mitochondria and xanthine oxidase.
In order to assess proliferation in NOX2 deﬁcient mice, we analyzed
the proportion of nestin and Ki-67 double positive cells in the DG
(Figs. 2I and 2J) and the SVZ (Figs. 2K and 2L). As shown in Fig. 2I-L,
the proportion of nestin-Ki67 positive cells is signiﬁcantly lower in the
DG and the SVZ from NOX2-deﬁcient mice suggesting that NOX2
deﬁciency is associated with a reduced proliferation of NPCs in adult
neurogenic regions.
We next analyzed mRNA levels of a panel of neuronal and neural
stem/progenitor markers [41] using qPCR in the two neurogenic
regions as well as in the OB, which is the projection zone of SVZ.
These results showed a clear impact of NOX2-deﬁciency: mRNA levels
for nestin (expressed in NSCs and NPCs), doublecortin (Dcx) (expressed
in young migrating neurons), BDNF (a soluble factor regulating
neurogenesis), Otx2 (neurogenesis transcription factor), as well as
NeuN (marker of mature neurons) were signiﬁcantly decreased in
NOX2-deﬁcient regions (Fig. 2M and S1F)[34]. Note, however, that
there were regional diﬀerences. While Otx2 was massively decreased in
the SVZ of NOX2-deﬁcient mice, there was no impact on expression in
the DG. Conversely, while there was a signiﬁcant decrease of BDNF in
the DG of NOX2-deﬁcient mice, BDNF was below detection levels in the
SVZ (as described previously [20] (Fig. 2M). No impact of NOX2
deﬁciency was observed on mRNA levels of the glutamatergic marker
mGluR, as well as the GABAergic markers Calb1 (Calbindin) and Gad67
(Fig. 2G). Interestingly, in the OB global neuronal and NPC markers
(Nestin, Otx2, Dcx, NeuN) were also decreased, despite the fact that
NOX2 levels in this region are low (Fig. 2M and S1F). Taken together
these results demonstrate a functional impact of NOX2 deﬁciency not
only on neural stem/precursor cells as well but also on the olfactory
bulb, a mature neural region.
2.2. Proliferation deﬁcit of NPCs derived from the neurogenic niche of
NOX2 deﬁcient mice
To asses further whether NOX2 aﬀects the stemness of NPCs, we
isolated NPCs from the neurogenic niches of WT and NOX2-deﬁcient
pups (P0 to P4). Relatively high level expression of NOX2 was observed
in the dissected regions (Fig. S2A) but, unlike the adult neurogenic
niches, the microglia markers IBA-1 and PU.1 were present (Fig. S2B;
note, however, that the microglia markers disappeared during neuro-
sphere formation, Fig. S2C). The dissected tissues were dissociated into
single cells and allowed to proliferate and form primary neurospheres
[33] (Fig. 3A, B). A serial dilution assay [11] indicated a decrease in the
number of formed neurospheres after 7 days at every dilution tested in
the NOX2-deﬁcient cultures, (Fig. 3C). To analyze the cellular composi-
tion of the neurospheres, we performed immunocytochemical staining
for nestin. The number of nestin-positive cells was strikingly reduced in
NOX2-deﬁcient neurospheres (Fig. 3D, E), strengthening the idea of a
decreased NSC pool in the absence of NOX2. The proliferation rate of
NSCs was evaluated using EdU pulse labeling assay. A decrease in the
percentage of EdU-positive cells in NOX2-deﬁcient neurospheres was
observed at 2, 4 and 8 h after incubation with EdU compared to WT
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neurospheres (Figs. 3F and 3G). The decreased number of proliferative
cells could be caused by an imbalance in the symmetric/asymmetric
divisions. An increase of asymmetric divisions would lead to a decrease
in the pool of undiﬀerentiated NSCs and to an increase in the number of
diﬀerentiated cells. To analyze this, we performed the cell-pair assay,
showing that asymmetric divisions (Fig. 3H-J) are more prominent in
NOX2-deﬁcient cultures suggesting that lack of NOX2 leads to a bias
towards asymmetric cell divisions.
Taken together, these results suggest that NOX2 deﬁciency di-
minishes self-renewal of NPCs through symmetric divisions, aﬀecting
the maintenance of stem cells pool.
2.3. Immunolocalization of NOX2 in Macaca fascicularis brain
To our knowledge, there are no useful antibodies to perform
immunohistochemistry of NOX2 in mouse tissues (available antibodies
lack speciﬁcity and sensitivity). However, there are very good immu-
nohistochemistry-compatible antibodies against human NOX2. In par-
ticular, there is the monoclonal 7D5 antibody, which has also been
shown to speciﬁcally recognize NOX2 in other primates [65]. We
therefore performed immunohistochemistry of the DG in the Macaca
fascicularis (macaque) brain (Fig. S3). DCX immunostaining (young
migrating neurons) showed a moderately intense, but clearly discern-
able staining in the DG, with a preferential staining of the SGZ (Fig.
S3A). Immunostaining of NOX2 revealed a remarkably intense staining
throughout the granular cell layer (GCL). A weaker staining of NOX2
could also be found in some adjacent areas. Although the exact nature
of these NOX2-expressing cells is unknown, immunohistochemistry in
the macaque brain conﬁrms that the high expression of NOX2 in the DG
is not limited to rodents, but is also observed in primates.
2.4. Role of NOX2 during neural diﬀerentiation of human iPSCs
To study the eﬀect of NOX2 deﬁciency on human neurogenesis, we
generated iPSCs from two diﬀerent types of CGD patients, X-linked
NOX2-deﬁcient patient (X°-CGD) and an autosomal-recessive p22phox-
deﬁcient patient (AR-22°-CGD) [6]. Two iPSC lines from healthy donors
(control-iPSCs) and the human ESC line H1 (H1-hESCs) were used as
control lines. As expected for cells that have acquired a pluripotent
state, these iPSCs showed typical morphology of hPSC colonies,
expressed markers of pluripotent cells and diﬀerentiated in vivo and
in vitro into the lineages derived from three embryonic germ-layers
mesoderm, ectoderm and endoderm (Fig. S4). We also conﬁrmed that,
like the parental ﬁbroblasts, the X°-CGD-iPSCs harbored the nonsense
Fig. 3. Impaired proliferation and altered balance in symmetric/asymmetric divisions of NSCs from NOX2-deﬁcient mice. (A) Schematic representation of generation of neurospheres
from subventricular zone (SVZ) and dentate gyrus (DG). (B) Light microscope pictures of the neurospheres derived from the SVZ of WT and NOX2-deﬁcient mice (NOX2-KO). (C) Dilution
assay and quantiﬁcation of neurosphere generation as a function of the initial number of seeded cells demonstrates decreased proliferation of NOX2-deﬁcient neural stem/precursor cells.
(D) Immunostaining of nestin within neurospheres. (E) Quantiﬁcation of nestin-staining in neurospheres (n=6) from D. (F) Representative image of EdU-labeled cells in neurospheres
after 8 h of incubation from WT and NOX-deﬁcient mice; (G) Quantiﬁcation of EdU incorporation after incubation of neurospheres during 2, 4 and 8 h. (H) Cell pair assay with SOX2
staining allows visualizing symmetric and asymmetric division of the cells; (I) representative image of SOX2 staining of WT and NOX2-deﬁcient neurospheres (J). Quantiﬁcation of
symmetric and asymmetric divisions in neurospheres from WT and NOX2-KO as percentage of dividing cells. Data were analyzed by Student's t-test and shown as mean
values± SEM.*P< 0.05, **P< 0.01, ***< 0.001.
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mutation (CgA→TgA) at the position 469 of exon 5 of the CYBB (NOX2)
gene leading to the absence of NOX2 mRNA and protein. The mutation
was absent in the iPSC control lines and present in all the X°CGD-iPSC
lines (Fig. S6A). Among the three CGD iPSC lines, one had large copy
number variations detected by CGH array and was therefore excluded
from further experiments (Fig. S5).
Based on the mouse data obtained in the ﬁrst part of this study, we
examined a possible role of NOX2 in neural diﬀerentiation of the
Fig. 4. NOX2 impacts early human neural diﬀerentiation in vitro. (A) Schematic representation of in vitro neural diﬀerentiation of human PSCs: undiﬀerentiated pluripotent stage (blue),
neural induction in neurosphere culture (pink) neural maturation on poly L-ornithine/laminin (green). DIV= days of in vitro. (B) Expression of CYBB (NOX2; B) and its subunit CYBA
(p22phox; C) was assessed in control hiPSCs (C3, C4 lines) and human ESC line H1 (H1-hESCs) at the undiﬀerentiated pluripotent stage (blue bar: day 0), after neural induction (red bar:
day 7) and during neuronal maturation (green bar: day 7–60). (D) Immunostaining demonstrates the absence of NOX2 protein in the pluripotent stage (day 0), the presence of NOX2
protein during the neural induction phase (day 7), and the absence of NOX2 protein in beta 3 tubulin-positive neurons (day 60). (E) Quantitative RT-PCR expression of a NPC marker
nestin (NES), transcription factors involved in neural fate and diﬀerentiation (OTX2 and NRSF/REST1) and a gene involved in neurodevelopment (DCX) in neurospheres derived from
control-iPSCs, X°-CGD-iPSCs and AR-22°-iPSCs (n=8). (F) Schematic representation of NOX2 rescue in the X°-CGD-iPSC line using a lentiviral vector expressing NOX2 and GFP. (G) High
expression of GFP in pluripotent colonies (day 0) and in neurospheres (day 7) derived from X°-CGD+NOX2-GFP-iPSC lines. (H) In neurospheres derived from the X°-CGD+NOX2-GFP-
iPSC line (day 7), the GFP ﬂuorescence (green) and positive NOX2 immunostaining (red) are observed. (I) Expression of NES, OTX2, NRSF/REST and DCX in neurospheres derived from
X°-CGD+NOX2-GFP-iPSCs. Data are shown as mean± SEM, n =9. Statistical analyses were done by one-way ANOVA followed by multiple comparisons Tukey's test. *P<0.05,
**P<0.01, ***< 0.001, ****< 0.0001. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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described iPSC lines, as well as the human embryonic pluripotent stem
cell line H1-hESCs (for protocol see Fig. 4A). We ﬁrst investigated the
temporal expression pattern of CYBB (NOX2) and CYBA (p22phox) by
quantitative RT-PCR (qRT-PCR) upon neural induction and neuronal
diﬀerentiation of control-iPSCs and H1-hESCs (Figs. 4B and 4C). As
shown in Fig. 4B, CYBB and CYBA expression was very low in
undiﬀerentiated control-iPSCs and H1-hESCs. Upon neural induction
into NPCs, the expression of both genes was strongly increased. In
contrast to CYBB which expression returns to baseline levels in neurons
(Fig. 4B), CYBA expression remains high (Fig. 4C). These results were
also conﬁrmed at the protein level showing (i) high expression of NOX2
in the NPCs and (ii) t absence of NOX2 protein in undiﬀerentiated iPSC
and in neurons. As expected, NOX2 protein was undetectable in X°-
CGD-iPSC-derived NPCs (Fig. 4D).
2.5. Neurogenesis impairment in NPCs derived from X°-CGD-iPSCs and AR-
22°-iPSCs
To investigate a possible functional impact of NOX2 deﬁciency on
early stage of neural induction, we measured by q-RT-PCR the expres-
sion of neural progenitor markers in neurospheres derived from control-
iPSCs, X°-CGD-iPSCs and AR-22°-iPSCs. Corroborating our observations
in the mouse brain, NOX2 deﬁciency was associated with a 4-fold
decrease of NES (Nestin) in NPCs (Fig. 4E). This was associated with a
decrease of the expression of transcription factors involved in neural
fate and diﬀerentiation such as OTX2 and NRSF/REST1 (Fig. 4E).
However, no diﬀerence in the expression of DCX was found between
NPCs derived from control-iPSCs, X°-CGD-iPSCs and AR-22°-iPSCs
(Fig. 4E).
To provide additional support for NOX2 involvement in the
defective neurogenesis of X°-CGD-iPSCs, we performed a rescue of
NOX2 expression in X°-CGD-iPSCs providing an isogenic iPSC-based
model. For this, X°-CGD-iPSCs were transduced with a lentiviral vector
carrying human CYBB (NOX2) cDNA and GFP as selection marker (Fig.
S6A). GFP-positive cells were selected by ﬂow cytometry sorting and
induced to diﬀerentiate into neurospheres (Fig. 4G). The obtained
rescue line will be referred to as X°-CGD+hNOX2. At the undiﬀer-
entiated pluripotent stage, X°-CGD+hNOX2 expressed mRNA for CYBB
(NOX2) (Fig. S6B), but no NOX2 immunoreactivity was observed (not
shown). This is possibly explained by the absence of p22phox in
undiﬀerentiated human PSCs (Fig. 4C), and the fact that NOX2 requires
p22phox for protein stability. However, upon diﬀerentiation of PSCs
towards neurospheres, p22phox expression increases (Fig. 4C), which
stabilizes the NOX2 protein and hence allows its detection (Fig. 4D).
Accordingly, a clear NOX2 staining could be observed in neurospheres
derived from the X°-CGD +hNOX2-iPSCs (Fig. 4H). Importantly, NOX2
rescue in neurospheres derived from X°-CGD-C6+hNOX2-iPSCs in-
creased the expression of the neural markers NES, OTX2, and NRSF/
REST1 (Fig. 4I), indicative of an improved neurogenesis.
2.6. Localization and activity of NOX2 in neural rosettes derived from PSCs
In order to identify which type of cells are expressing NOX2 during
neural induction, we used a co-immunostaining for NOX2 and the NPC
marker nestin in neurospheres derived from control and X°-CGD-iPSCs
[21]. Within neurospheres, we observed a clear population of cells with
nuclei-rich regions positive for both nestin and NOX2 (Fig. 5A), with
NOX2 staining occurring mostly in cell bodies, and nestin staining
extending to neurites (Fig. 5A, right panel). As expected, NOX2 was not
expressed in the X°-CGD neurospheres (Fig. 4A, lower panel, and
Fig. 5B). Interestingly, the number of nestin and Ki67 double positive
cells was lower in X°-CGD than in control neurospheres (Figs. 5C and
5D) while the fraction of young migratory -DCX-positive neurons was
similar in both groups (Figs. 5E and 5F).
To further investigate cellular localization of NOX2, we generated
neurospheres from H1-hESCs. Basically we observed two diﬀerent types
of rosettes in neurospheres derived from H1-hESCs: poly-rosette neuro-
spheres (Fig. 5G) and mono-rosette neurospheres (Fig. 5I). NOX2
staining was observed in inner cell layers of these rosettes (Figs. 5H
and 5J), which represent the in vitro analogue of the neural tube, where
neurogenesis is initiated [10,16]. To verify whether NOX2 is functional,
we used two diﬀerent probes to detect ROS, namely CellROX and
nitroblue tetrazolium (NBT). Fig. 5K shows an example of CellROX
visualization in a poly-rosette neurosphere. Intense red ﬂuorescence
indicates ROS generation, which was observed in the center of the
rosettes (Fig. 5K, left panel). After addition of the NOX inhibitor
diphenyleneiodonium (DPI), the red ﬂuorescence of CellROX decreased
(Figs. 5K and 5L), compatible with the concept that NOX2 is the source
of ROS generation. A blue formazan precipitate corresponding to NBT
reduction was observed in two diﬀerent mono-rosette neurospheres,
and was absent in rosettes pre-treated with DPI (Figs. 5M and 5N). Note
that addition of DPI to neurospheres would not remove already
established NBT precipitates.
2.7. Altered maturation of NPCs derived from NOX2-deﬁcient iPSCs into
neurons
Given the impact of NOX2 deﬁciency on diﬀerentiation of iPSCs into
NPCs, we further studied the eﬀect of NOX2 deﬁciency on later stages
of neural diﬀerentiation (Fig. 6). For this purpose, NPCs were plated on
polyornithin/laminin-coated dishes (at day 0) and allowed to mature
for 60 days. The expression of neuronal markers (TUBB3, MAP2 and
BDNF) was analyzed by RT-qPCR at diﬀerent time points of neural
diﬀerentiation (Figs. 6A, 6C and 6E) and by immunoﬂuorescence
staining at day 60 of neuronal diﬀerentiation (Figs. 6F, 6J, 6M, and
6P). Interestingly, neurons derived from X°-CGD-iPSCs and AR-22°-
CGD-iPSCs expressed lower levels of neuronal markers (TUBB3, MAP2
and BDNF) than those derived from control-iPSCs (Figs. 6A, 6C and 6E).
Consistent with these results, upon neuronal diﬀerentiation, X°-CGD-
iPSCs and AR-22°-CGD-iPSCs generated less β3-tubulin positive cells
and MAP2-positive cells (Figs. 6B and 6D). Quantiﬁcation of neurite
branching from soma of MAP2-positive neurons at day 60 of diﬀer-
entiation showed that the mean number of branches was lower in
neurons derived from X°-CGD-iPSCs and AR-22°-CGD-iPSCs compared
to those derived from control-iPSCs (Figs. 6F and 6G), which translates
into a reduced length of neurites in neurons derived from X°-CGD-iPSCs
and AR-22°-CGD-iPSCs (Fig. 6H).
Considering that an impaired maturation could explain the cogni-
tive impairment observed in CGD patients, we investigated the expres-
sion of both pre- and post-synaptic markers of neurons by RT-qPCR and
by immunoﬂuorescence analysis. As shown, no diﬀerence in SYN1,
SNAP25 and PSD95 expression was found in neurons derived from X°-
CGD-iPSCs, AR-22°-CGD-iPSCs and control-iPSCs (Fig. 6I). In line with
this, the density of synapsin punctae was similar in neurons derived
from X°-CGD-iPSCs, AR-22°-CGD-iPSCs and control-iPSCs (Figs. 6J and
6K).
In order to determine if the reduced number of neurons generated
from X°-CGD-iPSCs, AR-22°-CGD-iPSCs is associated with a gliogenic
shift, we analyzed the expression of astroglial (S100B and GFAP) and
oligodendroglial markers (OLIG1 and OLIG2) by RT-qPCR upon neuro-
nal diﬀerentiation of these iPSCs. Interestingly, no diﬀerence in the
expression of GFAP and S100B as well as in the number of GFAP-
positive cells was observed upon neuronal diﬀerentiation of X°-CGD-
and AR-22°-CGD-iPSCs (Figs. 6L, 6M and 6N). By contrast, upon
neuronal diﬀerentiation both X°-CGD- and AR-22°-CGD-iPSCs showed
a reduced expression of OLIG1 and OLIG2 as well as a reduced number
of OLIG2-positive cells (Figs. 6O, 6P and 6Q). Collectively, our results
suggest that NOX2 deﬁciency is associated with a reduced generation of
neurons and oligodendroglial cells with no impact in the number of
astroglial cells.
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3. Discussion
In this study, we show that the ROS-generating enzyme NOX2 is
highly expressed in neurogenic regions of the mouse and macaque
brain, as well as in neurally diﬀerentiated human iPS cells. Using
NOX2-deﬁcient mice and iPSC from NOX2-deﬁcient patients, we
demonstrate that NOX2 is functionally relevant in nestin positive
NPCs and their proliferation.
To our knowledge, this is the ﬁrst article that presents the role of
NOX2 during neural diﬀerentiation by using human NOX2 deﬁcient-
iPSC lines. Two previous studies have investigated the role of ROS, and
to some extent NOX, in NPCs. Le belle et al. has described the presence
of NOX2 in the SVZ and a role of ROS in the self-renewal and
multipotency of mouse NSCs. However, the conclusions of this study
was mostly based on the use of non-speciﬁc inhibitors [14,30]. have
shown NOX2-dependent regulation of proliferation and signaling in
adult mouse hippocampal precursor (AHP) cells and decrease NPC
proliferation NOX2-deﬁcient adult mouse dentate gyrus [14,30].
Our study provides several novel and relevant elements: i) we
investigated all NOX isoforms and demonstrate that only NOX2 mRNA
is speciﬁcally enriched in the DG and SVZ; ii) we excluded the
possibility that the presence of NOX2 in neurogenic regions is due to
microglia; iii) by demonstrating decreased oxidative modiﬁcations in
neurogenic regions of NOX2-deﬁcient animals, we demonstrated that
NOX2 is functional in neurogenic regions; iv) we detected region-
speciﬁc role of NOX2, which mediates BDNF generation in the dentate
gyrus, but Otx2 expression in the subventricular zone and olfactory
bulb.
The role of human NOX2 was studied using iPSC from two diﬀerent
patients, one with X-linked CYBB (NOX2) deﬁciency, and one with
autosomal CYBA (p22phox) deﬁciency. As discussed in the introduction,
p22phox is an obligatory subunit of the NOX2 complex, but in addition,
it is also part of the NOX1, NOX3, and NOX4 complex [3]. Globally
speaking, the results obtained with the two diﬀerent types of CGD iPSCs
were similar. However, the results obtained with the p22phox deﬁcient
cells (AR-22°) were more pronounced than the one observed with the
NOX2-deﬁcient cells. Thus, we cannot exclude a small contribution of
NOX1, NOX3, or NOX4 to ROS generation in neurogenesis. Note, that in
Fig. 5. NOX2 localization and activity in NPCs derived from iPSCs Immunoﬂuorescence images (A) and quantiﬁcation (B) of NOX2 (red) and the NPC marker nestin (green) in
neurospheres (day7) of control and X°-CGD-iPSCs. Images in panel (A) are shown at lower (left) and higher (right) magniﬁcations. (C) Co-staining of neurospheres with the proliferation
marker Ki-67 and the NPC marker nestin. (D) Quantiﬁcation of percentage of Ki67-nestin double positive cells. Immunostaining images (E) and quantiﬁcation (F) of the early neuronal
marker DCX (n=6). Formation of multiple small rosettes (G) and single large rosettes (I) in neurospheres (day 7) derived from H1-hESCs (light microscopy). (H, J) NOX2 immunostaining
in the two distinct types of rosette structures (right panels: higher magniﬁcation). (K, M) ROS production was visualized in neural rosette structures by using CellROX and NBT (yellow
arrows). Generation of ROS was decreased in presence of 10uM DPI (ﬂavoprotein inhibitor), arrows in yellow, suggesting NOX2 as a main source of ROS generation in rosettes (right
panels in K and M). (L and M) Dot plot graph demonstrating ROS measurement in neural rosettes using DPI (ﬂavoprotein inhibitor) (n=5). Statistics were done Student's t-test. *P<0.05,
**P<0.01, ***< 0.001, ****< 0.0001. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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contrast to the rapid down-regulation of NOX2 during neuronal
diﬀerentiation of human ESCs and iPSCs, there was a persistence of
p22phox expression, possibly compatible with a role of other NOX
enzymes during later stages of neuronal diﬀerentiation.
Also, a role for microglia during neurogenesis is emerging [50].
Thus a likely explanation for the presence of NOX2 in neurogenic zones
would be the presence of microglia, a CNS phagocyte which typically
expresses the phagocyte NADPH oxidase NOX2 [12,18,31,42,54,63].
However, the following arguments plead against a microglial localiza-
tion of NOX2 in neurogenic regions: i) NOX2-rich neurogenic regions of
the adult mouse brain contained only very low amounts of microglia; ii)
in vitro neuroectodermal diﬀerentiation of iPSCs is NOX2-regulated,
but no microglia (of mesodermal origin) is present under these
conditions; and iii) immunoﬂuorescence staining shows NOX2 within
rosette-like structures, which are analogous to the neural tube [16,17],
and it co-localization with the NPC marker nestin. Interestingly, the
presence of NOX2 appears to be required for symmetric divisions,
which might not be an independent eﬀect, but rather a mechanism that
contributes to the maintenance of the physiological number of prolif-
erating NSC. In the absence of this NOX2-driven oxidizing environment
there is a decrease in the neuroprecursor pool.
Eventually, at the ﬁnal stage of neural maturation, NOX2 appears to
be strongly down-regulated. This corroborates RNAseq data from a
mature neuronal region (cortex) where NOX2 is almost exclusively
detected in microglia and completely absent in mature neurons [68].
However our data do not formally exclude the possibility that low level
NOX2 expression may be present in neuronal subpopulations or at
speciﬁc developmental stages (for review see [42].
We observed particularities associated with the NOX2 expression in
neurogenic regions which merit discussion: i) NOX2 expression is not
accompanied by a detectable expression of the transcription factors
PU.1, which is one of the main known transcription factors driving
NOX2 expression in leukocytic cells [57]. This suggests a PU.1-
independent NOX2 expression in NPCs and the presence of alternative
transcriptional regulation of NOX2. ii) The expression levels of several
cytoplasmic NOX2 subunits (in particular p67phox, p40phox) were below
detection threshold. Yet, our data show that NOX2 is functional in
mouse and human NSCs/NPCs: NOX2 deﬁciency has a marked impact
on NSC/NPC proliferation and gene expression and NOX2 expression is
associated with ROS generation in neurogenic regions. Based on our
present knowledge of NOX2 biochemistry, it seems unlikely that NSCs/
NPCs exhibit a subunit-independent ROS generation by NOX2, but
rather that low level and/or intermittent expression of subunits suﬃces
to activate NOX2 in NSCs/NPCs; iii) the expression of the Rac GTPase
isoforms in the neurogenic regions of the mouse brain is also unique as
compared with other NOX2 expressing tissues. As expected, the
neutrophil-typical Rac2 is virtually absent. However, in addition to
Rac1, which is typically associated with NOX2 in macrophages,
neurogenic regions also express high levels of the neuronal Rac3
[37]. Thus, it is tempting to speculate that Rac3 might be implicated
in NOX2 activity in NSC/NPC.
In human phagocytes, activation of NOX2 is a tightly regulated
system which responds to speciﬁc stimuli and rapidly deactivates once
the relevant stimulus has disappeared. For the time being, we do not
have evidence that NOX2 in NSCs behaves in a similar way. Indeed,
under our experimental conditions, NOX2 appears to be active without
addition of a speciﬁc stimulus (data not shown). However, we observed
NOX2 activity in NSCs/NPCs within the neurogenic niche, where
various growth factors are released which contributes to the control
of the NSC/NPC system. Indeed, there is evidence for activation and/or
enhanced expression of NOX2 by neural growth factors such as FGF2
[14], BDNF [53] and VEGF [31]. For example, NOX2 expression is
decreased in neurogenic regions of VEGF-deﬁcient mice [31]. In
addition, there appears to be a feed-forward mechanism through a
redox-sensitive activation of the respective growth factor receptors by
NOX2 [62]. Thus, although we do not have experimental evidence for a
receptor-dependent activation of NOX2 in neural precursors, our data
certainly do not exclude this possibility.
Deﬁciency of NOX2 leads to a moderate decrease in cognitive
function in man [45] and mice [26]. Given recent results that connect
adult neurogenesis and learning [46,5,64], it is possible that the
defective neurogenesis caused by NOX2 deﬁciency plays a causal role
in the decreased cognition observed in CGD. This is also particularly
relevant with respect to BDNF, which is thought to play a role in
learning [22] and was found in our study to be decreased in human and
mouse carrying NOX2-loss of function mutations. Future studies are
needed to address whether learning associated neurogenesis is indeed
decreased in CGD mice.
These results likely explain a hitherto poorly understood phenotype
of NOX2-deﬁcient CGD patients. It also adds a new level of complexity
to the concept of NOX2 as a drug target for the treatment of oxidative
stress diseases of the CNS.
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